The anti-cancer effects of these compounds are associated with their modification effect on the central elements of various signaling pathways, including MAPK, PI3K, Akt, and mTOR, along with their effect on the tumor-suppressing p53 protein and RAS oncoproteins [34,81,82]. The gene discussed is MTOR; the disease is neoplasm.